Banner Wilbert Zwart Lymphnode Universe CMYK

Prostate cancer hijacks tumor cell biorhythm to evade hormone therapy


Hormone therapy is successful at keeping metastatic prostate cancer under control, but eventually the tumor cells become resistant to it. An unexpected potential solution has now emerged in medicines not designed to fight cancer, but to target proteins that regulate a cell’s circadian rhythm. 

An international team of researchers led by the Netherlands Cancer Institute will publish this discovery June 27, 2022, in the renowned journal Cancer Discovery, a journal of the American Association for Cancer Research.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.